Adage Capital Partners Gp, L.L.C. Relay Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,400,000 shares of RLAY stock, worth $4.75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,400,000
Previous 1,650,000
15.15%
Holding current value
$4.75 Million
Previous $11.7 Million
50.62%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RLAY
# of Institutions
207Shares Held
159MCall Options Held
100KPut Options Held
26.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$94.6 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$51 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$35.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$30.3 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$27.4 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $408M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...